Swiss National Bank’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
DG
Swiss National Bank's HCAT Position: Q2 2024 in Review
Swiss National Bank sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 112,200 shares — an estimated $845K sold.
Swiss National Bank first reported a position in HCAT in Q4 2019 and held it in 18 quarters. The position peaked at $4.58M in Q2 2021. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.
- Swiss National Bank reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
- Swiss National Bank sold 112,200 Health Catalyst shares in Q2 2024, an estimated $845K.
- Swiss National Bank first reported a position in Health Catalyst in Q4 2019 and held it in 18 quarters.
- Swiss National Bank's Health Catalyst position peaked at $4.58M in Q2 2021.
- 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.
Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.